Telmo Rodrigues
Universidad de Salamanca(ES)Centro de Investigación del Cáncer(ES)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Protein Kinase Regulation and GTPase Signaling, Silicon Carbide Semiconductor Technologies, Receptor Mechanisms and Signaling, Adenosine and Purinergic Signaling
Most-Cited Works
- → The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin(2015)98 cited
- → RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade(2024)48 cited
- → Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin(2017)1 cited